Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disorders”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Testing effectiveness (Phase 2)Study completedNCT04670770
What this trial is testing

An Open Label Study of the Effects of SHR1459 in NMOSDs Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Reistone Biopharma Company Limited 10
Not applicableLooking for participantsNCT07762872
What this trial is testing

Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Junwei Hao, MD 50
Testing effectiveness (Phase 2)Looking for participantsNCT05549258
What this trial is testing

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 15
Not applicableStudy completedNCT04388072
What this trial is testing

An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
First Affiliated Hospital of Fujian Medical University 200
Not applicableStudy completedNCT04202055
What this trial is testing

Immunologic Biomarker Profile of Cerebrospinal Fluid

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
Centre Hospitalier Universitaire de Nīmes 165
Early research (Phase 1)Study completedNCT02283671
What this trial is testing

Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
Sara Varea 20
Early research (Phase 1)Study completedNCT04227470
What this trial is testing

HBM9161 in NMOSD Patients

Who this might be right for
NMO Spectrum Disorder
Harbour BioMed (Guangzhou) Co. Ltd. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06697535
What this trial is testing

Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd 35
Not applicableActive Not RecruitingNCT06906692
What this trial is testing

Meningococcal Vaccination in Patients on Complement Inhibitors

Who this might be right for
Myasthenia Gravis GeneralisedVaccinationComplement System+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 35
Large-scale testing (Phase 3)Active Not RecruitingNCT06724809
What this trial is testing

Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD

Who this might be right for
NMOSDNeuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00904826
What this trial is testing

An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica

Who this might be right for
Neuromyelitis OpticaDevic's Disease
Mayo Clinic 14
Not applicableUnknownNCT05605951
What this trial is testing

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

Who this might be right for
Demyelinating DiseasesMultiple SclerosisNeuromyelitis Optica Spectrum Disorder Attack+2 more
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul 200
Not applicableActive Not RecruitingNCT01623076
What this trial is testing

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderTransverse Myelitis+1 more
University of Texas Southwestern Medical Center 150
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Testing effectiveness (Phase 2)Looking for participantsNCT05504694
What this trial is testing

Ofatumumab in AQP4-IgG Seropositive NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 5
Not applicableUnknownNCT03370965
What this trial is testing

Optic Neuritis Differential Diagnosis Study

Who this might be right for
Optic NeuritisNeuromyelitis OpticaMultiple Sclerosis
University Hospital Center of Martinique 150
Large-scale testing (Phase 3)UnknownNCT00004645
What this trial is testing

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

Who this might be right for
Acute Disseminated EncephalomyelitisDevic's SyndromeMarburg's Variant of Multiple Sclerosis+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 22
Early research (Phase 1)Looking for participantsNCT07526493
What this trial is testing

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorder (NMOSD)Autoimmune Encephalitis (AE)+4 more
Tongji Hospital 6
Next Page